GHSR-1a is not Required for Ghrelin’s Anti-inflammatory and Fat-sparing Effects in Cancer Cachexia
Authors:
- Haiming LiuHLHaiming Liu
- Jiaohua LuoJLJiaohua Luo
- Bobby GuilloryBGBobby Guillory
- Ji-An ChenJCJi-An Chen
- Pu ZangPZPu Zang
- Jordan K. YoeliJYJordan K. Yoeli
- Yamileth HernandezYHYamileth Hernandez
- Ian (In-Gi) LeeILIan (In-Gi) Lee
- Barbara AndersonBABarbara Anderson
- Mackenzie J. StorieMSMackenzie J. Storie
- Alison TewnionATAlison Tewnion
- Jose M. GarciaJGJose M. Garcia
Preprint
- 6 December 2019
- preprint
- Published by Cold Spring Harbor Laboratory in bioRxiv
- p. 866376
Abstract
Adipose tissue (AT) atrophy is a hallmark of cancer cachexia contributing to increased morbidity/mortality. Ghrelin has been proposed as a treatment for cancer cachexia partly by preventing AT atrophy. However, the mechanisms mediating ghrelin’s effects are incompletely understood, including the extent to which its only known receptor, GHSR-1a, is required for these effects. This study characterizes the pathways involved in AT atrophy in the Lewis Lung Carcinoma (LLC)-induced cachexia model and those mediating the effects of ghrelin in Ghsr+/+ and Ghsr−/− mice. We show that LLC causes AT atrophy by inducing anorexia, and increasing AT inflammation, thermogenesis and energy expenditure. These changes were greater in Ghsr−/−. Ghrelin administration prevented LLC-induced anorexia only in Ghsr+/+, but prevented WAT inflammation and atrophy in both genotypes, although its effects were greater in Ghsr+/+. LLC-induced increases in BAT inflammation, WAT and BAT thermogenesis, and energy expenditure were not affected by ghrelin. In conclusion, ghrelin ameliorates WAT inflammation, fat atrophy and anorexia in LLC-induced cachexia. GHSR-1a is required for ghrelin’s orexigenic effect but not for its anti-inflammatory or fat-sparing effects.Keywords
This publication has 87 references indexed in Scilit:
- A guide to analysis of mouse energy metabolismNature Methods, 2011
- Central nervous system inflammation induces muscle atrophy via activation of the hypothalamic–pituitary–adrenal axisJournal of Experimental Medicine, 2011
- Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissuesAging Cell, 2011
- Ghrelin‐induced adiposity is independent of orexigenic effectsThe FASEB Journal, 2011
- Definition and classification of cancer cachexia: an international consensusThe Lancet Oncology, 2011
- Fibrosis in Human Adipose Tissue: Composition, Distribution, and Link With Lipid Metabolism and Fat Mass LossDiabetes, 2010
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Ghrelin Treatment of Chronic Kidney Disease: Improvements in Lean Body Mass and Cytokine ProfileEndocrinology, 2007
- Characterization of Adult Ghrelin and Ghrelin Receptor Knockout Mice under Positive and Negative Energy BalanceEndocrinology, 2007
- Adipose tissue in Walker 256 tumour-induced cachexia: possible association between decreased leptin concentration and mononuclear cell infiltrationCell and tissue research, 2004